Dow Jones Industrial Average, Bank of America Corp, Microsoft Corporation, Goldman Sachs Group Inc. Read 's Market Analysis on Investing.com ...
The introduction of AbbVie’s hepatitis C drugs in 2014 forced Gilead’s hand in the fight for market dominance in hepatitis C.